RBF Capital’s Teladoc Health TDOC Stock Holding History

RBF Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,000	Closed	-$546K	–	501
2021 Q1	$546K	Buy	+3,000	New	+$696K	0.03%	313

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

RBF Capital's TDOC Position: Q2 2021 in Review

RBF Capital sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 3,000 shares — an estimated $546K sold.

RBF Capital first reported a position in TDOC in Q1 2021 and held it in 1 quarter. The position peaked at $546K in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

RBF Capital reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
RBF Capital sold 3,000 Teladoc Health shares in Q2 2021, an estimated $546K.
RBF Capital first reported a position in Teladoc Health in Q1 2021 and held it in 1 quarter.
RBF Capital's Teladoc Health position peaked at $546K in Q1 2021.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on RBF Capital's 13F filing for Q2 2021, filed 16 Aug 2021.